Autism Speaks' Autism Tissue Program (ATP) will transition to the Autism BrainNet. Resources from the ATP will continue to be made available through Harvard University in Boston. Communication with ATP donor families will continue through Autism BrainNet, and ATP registrants will be added to the Autism BrainNet database to receive updates on the new program and news about general brain research.
Dr. David Amaral of the University of California MIND Institute will serve as the Director of the Autism BrainNet. "Studies on brain tissue represent the best way for researchers to gain a deeper understanding of the genetic, cellular and molecular causes of autism spectrum disorder," Amaral says. "This research takes us important steps closer to effective treatments that will lessen disability for affected individuals."
"Human brain structure and function is the key to understanding behavior and identifying differences in the brains of individuals with autism is essential for advancing our understanding of autistic behaviors," said Marta Benedetti, Senior Scientist at the Simons Foundation Autism Research Initiative. "Autism BrainNet will provide the material needed to identify and understand these differences, and will greatly advance our understanding of and the ability to treat autism. Autism BrainNet will also allow researchers to replicate previous findings using new, better-characterized and larger sets of tissue."
"Since it was launched in 1998 the Autism Speaks Autism Tissue Program has been committed to providing the rare and precious resource of brain tissue to many highly qualified scientists," said Autism Speaks chief science officer Robert Ri
|Contact: Steffanie Marchese|